Standard BioTools Inc (LAB)
2.54
+0.06
(+2.42%)
USD |
NASDAQ |
May 01, 16:00
2.54
0.00 (0.00%)
After-Hours: 20:00
Standard BioTools Debt to Equity Ratio: -0.429 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.429 |
| September 30, 2023 | -0.4904 |
| June 30, 2023 | -0.5754 |
| March 31, 2023 | -0.6697 |
| December 31, 2022 | -0.7965 |
| September 30, 2022 | -1.031 |
| June 30, 2022 | -1.723 |
| March 31, 2022 | 4.524 |
| December 31, 2021 | 0.7511 |
| September 30, 2021 | 0.6447 |
| June 30, 2021 | 0.4929 |
| March 31, 2021 | 0.4379 |
| December 31, 2020 | 0.39 |
| September 30, 2020 | 0.3561 |
| June 30, 2020 | 0.407 |
| March 31, 2020 | 0.3811 |
| December 31, 2019 | 0.3504 |
| September 30, 2019 | 0.3066 |
| June 30, 2019 | 0.2887 |
| March 31, 2019 | 0.2731 |
| December 31, 2018 | 2.386 |
| September 30, 2018 | 7.556 |
| June 30, 2018 | 4.787 |
| March 31, 2018 | 3.380 |
| December 31, 2017 | 6.311 |
| Date | Value |
|---|---|
| September 30, 2017 | 4.995 |
| June 30, 2017 | 8.150 |
| March 31, 2017 | 5.065 |
| December 31, 2016 | 3.662 |
| September 30, 2016 | 2.867 |
| June 30, 2016 | 2.312 |
| March 31, 2016 | 1.968 |
| December 31, 2015 | 1.694 |
| September 30, 2015 | 1.576 |
| June 30, 2015 | 1.468 |
| March 31, 2015 | 1.372 |
| December 31, 2014 | 1.299 |
| September 30, 2014 | 1.264 |
| June 30, 2014 | 1.207 |
| March 31, 2014 | 1.166 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.0183 |
| June 30, 2012 | 0.0961 |
| March 31, 2012 | 0.1222 |
| December 31, 2011 | 0.1782 |
| September 30, 2011 | 0.1959 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-1.723
Minimum
Jun 2022
4.524
Maximum
Mar 2022
0.1902
Average
0.3504
Median
Dec 2019
Debt to Equity Ratio Benchmarks
| Bruker Corp | 0.9305 |
| Azenta Inc | 0.00 |
| Harvard Bioscience Inc | 0.5004 |
| Bionano Genomics Inc | 0.7259 |
| Akoya Biosciences Inc | 1.400 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 323.07M |
| Total Liabilities (Quarterly) | 471.12M |
| Shareholders Equity (Quarterly) | -148.05M |
| Current Ratio | 1.447 |
| Net Debt Paydown Yield | 0.14% |